CA-LANDMARK-WORLDWIDE
Landmark (Landmark Worldwide ), established in 1991, celebrates its 30th anniversary with more than three million people across the globe having been positively and powerfully contributed to and empowered by its programs. Marking a related anniversary, it was 50 years ago that the ideas that grew into Landmark were born with the delivery of the first est Training in 1971.
As the leader in the personal and professional growth, training and development industry, Landmark’s programs and ideas have empowered people for five decades to dramatically elevate the quality of their lives and, in addition, to impact the areas of their lives that matter most to them.
Marketdata Enterprises, Inc., publishers of the definitive report on the personal development industry in the United States, stated in their 2021 report:
- “Landmark was named one of the top training and development companies in the world by HR.com/James McNeil.”
- “Landmark is recognized for having one of the best faculty bodies in the business,” and many professionals “in the personal development and coaching industries got their start by participating in Landmark’s programs.”
- Landmark is unique in the industry as the “sole program provider of ontological transformation … a transformation in being – a breakthrough that results in immediate, lasting, and dramatic shifts in people’s effectiveness and quality of life.”
50 years ago, Werner Erhard’s est Training launched the personal development industry and the beginning of what has since become the business and life coaching industry. Many of his concepts have earned a lasting place in mainstream culture, business and academia. As TIME magazine recognized, “The American obsession with transformation isn’t new. It’s about as old as the nation, but it was Werner Erhard ... who created the first modern transformation when he founded est seminars in 1971.”
Erhard retired the est Training and launched a new course, The Forum, in 1985. Erhard’s ideas (as expressed in his programs) are examined in detail by two scholars in the best-selling book, Speaking Being : Werner Erhard, Martin Heidegger, and a New Possibility of Being Human.
Described as “one of the most incisive and insightful thinkers of our generation" by David Eagleman, Ph.D., Stanford University neuroscientist and New York Times bestselling author, Erhard has committed the majority of his intellectual efforts over the past three decades to the academic world. With his colleagues, he is writing university-level curricula and teaching and lecturing at universities including the UCLA Anderson School of Management, the United States Air Force Academy, Stanford University, Harvard University, Yale University, Dartmouth College, and Erasmus University.
Today, Landmark continues to make its programs available throughout the world, including having launched virtually all of its more than 50 programs online. Landmark has been and continues to be endorsed by thousands of renowned leaders worldwide, including CEOs of global corporations, widely respected academics, and internationally recognized humanitarians.
“What greatly impressed me with regard to Landmark is it gives people a hands-on access to altering the culture of an organization and to effect significant change in a surprisingly short period of time.”
~ Michael C. Jensen, Jesse Isidor Straus Professor of Business Administration, Emeritus at Harvard University
“Winning a gold medal at the Olympics was extraordinary and, when I did The Landmark Forum, I realized I could have that same level of accomplishment, fulfillment, and joy in every part of my life.”
~ Natalie Cook, Olympic Gold Medalist
“As a person whose life is about global issues, I can’t think of a more effective training program. One of the most valuable results I got was the ability to deal with intractable global problems without getting discouraged. As a result of participating in Landmark, individuals gain the tools to go out into the world and make things happen.”
~ Dr. Charles McNeill, Senior Policy Advisor, United Nations Environment Programme
“I have yet to see anything else that has such a positive impact on people’s ability to relate, communicate, and perform as Landmark.”
~ Paul Fireman, Founder and former Chairman/CEO of Reebok International, Ltd. USA
Landmark’s global management consulting firm and subsidiary, Vanto Group was named one of America’s Best Management Consulting Firms by Forbes Magazine for two consecutive years – 2020 and 2021. In addition, Landmark is the primary catalyst for participants creating more than 150,000 non-profit and pro bono projects, benefiting individuals, organizations, and communities around the world. A few examples include:
- Special Spectators (for which founder, Blake Rockwell was named a CNN Hero) has had a significant impact on tens of thousands of seriously ill children, their siblings and parents by giving them a VIP access game day experience at more than 50 major colleges and universities.
- Plant a Million Trees: Gashaw Tahir founded an NGO called Greenland Development Foundation that planted more than a million trees in Ethiopia and, in the process, put more than 450 young people to work, giving them not only a sense of dignity, but the ability to see a future in Ethiopia.
- R U OK? Day : A suicide prevention project that has been embraced by the entire country of Australia.
Landmark acknowledges and thanks the more than three million people who have participated in its work and the difference they make in their own lives, in the lives of others, and throughout the world.
For more information about Landmark and its programs, visit www.landmarkworldwide.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210916005243/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
